PK
Therapeutic Areas
Surface Ophthalmics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Kera Sol Tears | Dry Eye Syndrome | Phase 2 |
| Mycosol (Surf-101) | Dry Eye Syndrome / Ocular Surface Disease | Phase 2 |
| Betasol (Surf-201) | Dry Eye Syndrome / Ocular Inflammation | Phase 2 |
| Drug | Indication | Phase |
|---|---|---|
| Kera Sol Tears | Dry Eye Syndrome | Phase 2 |
| Mycosol (Surf-101) | Dry Eye Syndrome / Ocular Surface Disease | Phase 2 |
| Betasol (Surf-201) | Dry Eye Syndrome / Ocular Inflammation | Phase 2 |